Successful percutaneous aortic valve implantation via a stenotic left subclavian artery access.
Severe aortic valve stenosis may be tackled with percutaneous aortic valve replacement instead of surgical replacement. At present, two CE marked prosthetic valves are available. The CoreValve ReValving System is primarily designed to be introduced transfemorally, while implantation via subclavian arteries has been described in cases of unsuitable femoral access. However, this route has been used when subclavian artery is free of disease. In this case report we describe a successful CoreValve ReValving System implantation via a diseased and tortuous left subclavian artery after predilatation balloon angioplasty. The prosthesis was then advanced in the native aortic valve, deployed, and successfully implanted. Techniques and manipulations are provided.
Vavuranakis
Manolis
M
First Department of Cardiology, Hippokration Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece. vavouran@otenet.gr
Vrachatis
Dimitrios A
DA
Toutouzas
Konstantinos
K
Economopoulos
George
G
Kalogeras
Konstantinos I
KI
Stefanadis
Christodoulos
C
D000369:Aged, 80 and over; D000800:Angioplasty, Balloon; D001024:Aortic Valve Stenosis / Q000150:complications / Q000628:therapy*; D006328:Cardiac Catheterization / Q000295:instrumentation; D005260:Female; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D011474:Prosthesis Design; D012720:Severity of Illness Index; D013349:Subclavian Steal Syndrome / Q000150:complications / Q000000981:diagnostic imaging / Q000628:therapy*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome